Ikemura Shinnosuke 池村辰之介

… Alternative Names

IKEMURA Shinnosuke 池村辰之介

Less

Researcher Number	30445291
Affiliation (Current)	2025: 山梨大学, 大学院総合研究部, 特任講師
Affiliation (based on the past Project Information) *help	2022 – 2025: 山梨大学, 大学院総合研究部, 特任講師 2021: 慶應義塾大学, 医学部(信濃町), 講師 2018 – 2020: 慶應義塾大学, 医学部(信濃町), 助教 2013: 慶應義塾大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 53030:Respiratory medicine-related / Basic Section 50010:Tumor biology-related Except Principal Investigator Basic Section 53030:Respiratory medicine-related / Clinical oncology
Keywords	Principal Investigator 肺癌 / 作用機序 / 薬剤感受性 / 抗体薬物複合体 / Patritumab-Deruxtecan / 精密医療 / 分子生物学的診断 / 病理学的診断 / オルガノイド培養 / 希少遺伝子変異 … More / BRAF遺伝子変異肺癌 / BRAF遺伝子変異 / 希少肺癌 / BRAF / 非小細胞肺癌 … More Except Principal Investigator 転写因子 / オルガノイド / Wntシグナル / KRAS変異 / 肺癌 / PI3キナーゼ / 繊維芽細胞増殖因子 / 分子標的治療 / 線維芽細胞増殖因子 / 上皮成長因子受容体阻害剤 / 耐性肺癌 Less

肺癌細胞株を用いたPatritumab-Deruxtecanのバイオマーカー、作用・耐性機序の探索Principal Investigator
- Principal Investigator
  
  池村辰之介
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  University of Yamanashi
脱細分化を指向した肺癌の新たな治療戦略の提案
- Principal Investigator
  
  副島研造
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  University of Yamanashi
Research on pathological diagnosis, genetic analysis, and therapeutic efficacy using patient-derived organoidsPrincipal Investigator
- Principal Investigator
  
  Ikemura Shinnosuke
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  University of Yamanashi
  Keio University
Research of clinical profile and drug sensitivity of BRAF mutation-positive lung cancerPrincipal Investigator
- Principal Investigator
  
  IKEMURA Shinnosuke
- Project Period (FY)
  2018 – 2019
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Keio University
Overcoming epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)-resistance in lung cancer through PI3-kinase pathway
- Principal Investigator
  
  NAOKI Katsuhiko
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Clinical oncology
- Research Institution
  Keio University

All 2023 2014 2013 2012 2011 Other

All Journal Article Presentation

[Journal Article] Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma2023
- Author(s)
  Ebisudani Toshiki, Hamamoto Junko, Togasaki Kazuhiro, et al.
- Journal Title
  
  Cell Reports
  
  Volume: 42 Issue: 3 Pages: 112212-112212
- DOI
  10.1016/j.celrep.2023.112212
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16028, KAKENHI-PROJECT-19H03671, KAKENHI-PROJECT-20H03757, KAKENHI-PROJECT-21H02765, KAKENHI-PROJECT-22KJ2666, KAKENHI-PROJECT-20K08574, KAKENHI-PROJECT-22H04995
[Journal Article] Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.2014
- Author(s)
  Ohgino K, Soejima K, Yasuda H, Hayashi Y, Hamamoto J, Naoki K, Arai D, Ishioka K, Sato T, Terai H, Ikemura S, Yoda S, Tani T, Kuroda A, Betsuyaku T.
- Journal Title
  
  Lung Cancer
  
  Volume: 83 Issue: 1 Pages: 90-6
- DOI
  10.1016/j.lungcan.2013.10.016
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390218, KAKENHI-PROJECT-23501311
[Journal Article] Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC Cells.2013
- Author(s)
  Terai H, Soejima K, Yasuda H, et al
- Journal Title
  
  Mol Cancer Res
  
  Volume: 印刷中 Issue: 7 Pages: 759-767
- DOI
  10.1158/1541-7786.mcr-12-0652
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590870, KAKENHI-PROJECT-23501311, KAKENHI-PROJECT-24790822
[Journal Article] Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma2013
- Author(s)
  Hamamoto J, Soejima K, Yoda S, Naoki K, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, Hayashi Y, Sakamoto M, Takebayashi T, Betsuyaku T
- Journal Title
  
  Molecular Medicine Reports
  
  Volume: 8(2) Issue: 2 Pages: 456-462
- DOI
  10.3892/mmr.2013.1517
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] CHARACTERISTICS OF RE-BIOPSIED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS2013
- Author(s)
  Daisuke Arai, Kenzo Soejima, Hiroyuki Yasuda, Tetsuo Tani, Aoi Kuroda, Kota Ishioka, Keiko Ohgino, Takashi Sato, Hideki Terai, Shinnosuke Ikemura, Junko Hamamoto, Katsuhiko Naoki, Yuichiro Hayashi, Tomoko Betsuyaku
- Organizer
  第15回世界肺癌学会総会
- Place of Presentation
  オーストラリア(シドニー)
- Year and Date
  2013-10-28
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] CHARACTERISTICS OF RE-BIOPSIED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS2013
- Author(s)
  Daisuke Arai, Kenzo Soejima, Hiroyuki Yasuda, Tetsuo Tani, Aoi Kuroda, Kota Ishioka, Keiko Ohgino, Takashi Sato, Hideki Terai, Shinnosuke Ikemura, Junko Hamamoto, Katsuhiko Naoki, Yuichiro Hayashi, Tomoko Betsuyaku
- Organizer
  第15回世界肺癌学会総会
- Place of Presentation
  オーストラリア（シドニー）
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] EXPRESSION OF FIBROBLAST GROWTH FACTOR-9 IS ASSOCIATED WITH POOR PROGNOSIS OF RESECTED NON-SMALL CELL LUNG CANCER PATIENTS2013
- Author(s)
  Keiko Ohgino, Kenzo Soejima, Hiroyuki Yasuda, Yuichiro Hayashi, Tetsuo Tani, Aoi Kuroda, Daisuke Arai, Kota Ishioka, Takashi Sato, Hideki Terai, Shinnosuke Ikemura, Sohei Nakayama, Satoshi Yoda, Junko Hamamoto, Katsuhiko Naoki, Tomoko Betsuyaku
- Organizer
  第15回世界肺癌学会総会
- Place of Presentation
  オーストラリア（シドニー）
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] EXPRESSION OF FIBROBLAST GROWTH FACTOR-9 IS ASSOCIATED WITH POOR PROGNOSIS OF RESECTED NON-SMALL CELL LUNG CANCER PATIENTS2013
- Author(s)
  Keiko Ohgino, Kenzo Soejima, Hiroyuki Yasuda, Yuichiro Hayashi, Tetsuo Tani, Aoi Kuroda, Daisuke Arai, Kota Ishioka, Takashi Sato, Hideki Terai, Shinnosuke Ikemura, Sohei Nakayama, Satoshi Yoda, Junko Hamamoto, Katsuhiko Naoki, Tomoko Betsuyaku
- Organizer
  第15回世界肺癌学会総会
- Place of Presentation
  オーストラリア(シドニー)
- Year and Date
  2013-10-29
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] Activation of FGF2-FGFR1 pathway in EGFR-mutant lung cancer cell line with long-term gefitinib exposure2013
- Author(s)
  Terai H, Soejima K, Naoki K, Yasuda H, Satomi R, Nakayama S, Yoda S, Ikemura S, Sato T, Ishioka K, Arai D, Ohgino K, Tani T, Kuroda A, Hamamoto J, Betsuyaku TTerai H, Soejima K, Naoki K, Yasuda H, Satomi R, Nakayama S, Yoda S, Ikemura S, Sato T, Ishioka K, Arai D, Ohgino K, Tani T, Kuroda A, Hamamoto J, Betsuyaku T
- Organizer
  2013 AACR Annual Meeting
- Place of Presentation
  USA (Washington DC)
- Year and Date
  2013-04-10
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] 長期ゲフィチニブ曝露によるEGFR 変異肺癌細胞株におけるFGF2-FGFR1 経路の活性化2012
- Author(s)
  寺井秀樹、副島研造、猶木克彦、安田浩之、池村辰之介、佐藤崇、荒井大輔、石岡宏太、扇野圭子、浜本純子、別役智子
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌
- Year and Date
  2012-09-20
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] Expression of fibroblast growth factor-9 is associated with poor prognosis of resected non-small cell lung cancer patients2012
- Author(s)
  Keiko Ohgino, Kenzo Soejima, Daisuke Arai, Kota Ishioka, Takashi Sato, Hideki Terai, Shinnosuke Ikemura, Satoshi Yoda, Junko Hamamoto, Katsuhiko Naoki, Tomoko Betsuyaku
- Organizer
  AACR Annual Meeting 2012
- Place of Presentation
  USA (Chicago)
- Year and Date
  2012-04-03
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] Aberrant DNA methylation and expression of mRNA in EGFR-mutant lung cancer cell line with long-term gefitinib exposure2011
- Author(s)
  Terai H, Soejima K, Naoki K, Satomi R, Nakayama S, Yoda S, Ikemura S, Sato T, Hamamoto J, Asano K, Betsuyaku T
- Organizer
  第69回日本癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] 長期ゲフィチニブ曝露によるEGFR変異肺癌細胞株におけるFGF2-FGFR1経路の活性化
- Author(s)
  寺井秀樹、副島研造、猶木克彦、安田浩之、池村辰之介、佐藤崇、荒井大輔、石岡宏太、扇野圭子、浜本純子、別役智子
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-23501311
[Presentation] Expression of fibroblast growth factor-9 is associated with poor prognosis of resected non-small cell lung cancer patients.
- Author(s)
  Keiko Ohgino, Kenzo Soejima, Daisuke Arai, Kota Ishioka, Takashi Sato, Hideki Terai, Shinnosuke Ikemura, Satoshi Yoda, Junko Hamamoto, Katsuhiko Naoki, Tomoko Betsuyaku.
- Organizer
  AACR Annual Meeting 2012
- Place of Presentation
  USA (Chicago)
- Data Source
  KAKENHI-PROJECT-23501311

1. SOEJIMA Kenzo (30236145)

# of Collaborated Projects: 3 results

# of Collaborated Products: 12 results
2. NAOKI Katsuhiko (40265806)

# of Collaborated Projects: 1 results

# of Collaborated Products: 11 results
3. HAMAMOTO Junko (40570239)

# of Collaborated Projects: 1 results

# of Collaborated Products: 11 results
4. 安田浩之 (70365261)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. BETSUYAKU Tomoko

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. TERAI Hideki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 戸ヶ崎和博

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ikemura Shinnosuke 池村 辰之介

IKEMURA Shinnosuke 池村 辰之介

Research Projects

Research Products

Co-Researchers

肺癌細胞株を用いたPatritumab-Deruxtecanのバイオマーカー、作用・耐性機序の探索Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

脱細分化を指向した肺癌の新たな治療戦略の提案

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Research on pathological diagnosis, genetic analysis, and therapeutic efficacy using patient-derived organoidsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Research of clinical profile and drug sensitivity of BRAF mutation-positive lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Overcoming epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)-resistance in lung cancer through PI3-kinase pathway

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC Cells.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma2013

Author(s)

Journal Title

DOI

Data Source

[Presentation] CHARACTERISTICS OF RE-BIOPSIED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS2013

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] CHARACTERISTICS OF RE-BIOPSIED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS2013

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] EXPRESSION OF FIBROBLAST GROWTH FACTOR-9 IS ASSOCIATED WITH POOR PROGNOSIS OF RESECTED NON-SMALL CELL LUNG CANCER PATIENTS2013

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] EXPRESSION OF FIBROBLAST GROWTH FACTOR-9 IS ASSOCIATED WITH POOR PROGNOSIS OF RESECTED NON-SMALL CELL LUNG CANCER PATIENTS2013

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Activation of FGF2-FGFR1 pathway in EGFR-mutant lung cancer cell line with long-term gefitinib exposure2013

Author(s)

Organizer

Ikemura Shinnosuke 池村辰之介

IKEMURA Shinnosuke 池村辰之介